Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,719 total articles
Stephen R. Palmer, the Vice President of Accounting at Carvana Co. (NASDAQ: CVNA), has completed a sale of company stock totaling $395,320. The transaction, which involved 1,000 shares of Class A Common Stock, was carried out at a price of $395.32 per share on May 1, 2026. This divestment was not an impromptu market move but was executed under a Ru…
Steve Gassen, the Executive Vice President of Geographies at SLB LIMITED/NV (NYSE:SLB), has completed a series of significant share transactions totaling approximately $2,998,766. Reported on May 1, 2026, the sale involved a total of 53,379 shares of common stock. This move follows Gassen's exercise of non-qualified stock options, occurring at a ti…
A recent regulatory filing with the Securities and Exchange Commission has detailed a series of stock transactions by Michael McRoberts, a Director and Senior Advisor at Rush Enterprises Inc. (NASDAQ:RUSHA). On April 30, 2026, Mr. McRoberts engaged in both the acquisition of shares through option exercises and the subsequent sale of equity. The tra…
Immunovant, Inc. (NASDAQ:IMVT) director Robert Susman has completed a sale of company stock totaling $67,979. The transaction, which took place on May 1, 2026, involved the disposal of 2,502 shares of common stock. Prices for the shares sold fluctuated between $26.84 and $27.49, resulting in a weighted average execution price of $27.17 per share. T…
Oruka Therapeutics, Inc. (NASDAQ:ORKA) recently saw insider activity from its Chief Operating Officer, Laura Lee Sandler. According to SEC filings, Sandler engaged in a series of transactions on May 1, 2026, involving the company's common stock. These movements included both the acquisition of shares through warrant exercises and the subsequent sal…
Frances Arnold, a member of the Board of Directors at Alphabet Inc. (NASDAQ:GOOGL), has completed a sale of company stock. On April 30, 2026, Ms. Arnold disposed of 102 shares of Alphabet's Class C Capital Stock. The transaction was executed at a price of $371.00 per share, resulting in total proceeds of $37,842. This divestment was carried out und…
Brandon F. Lombardi, serving as the Chief Legal Officer for Sprouts Farmers Market, Inc. (NASDAQ: SFM), has completed a sale of company common stock. The transaction, reported on May 1, 2026, involved the sale of 406 shares for a total value of $33,307. This insider activity occurs against a backdrop of recent financial reporting and adjusted analy…
Richard Todd Schwartz, the Chief Executive Officer of Rush Street Interactive, Inc. (NASDAQ: RSI), completed a sale of 158,335 shares of Class A Common Stock on May 1, 2026. The transaction, valued at approximately $4.45 million, was conducted through a pre-established Rule 10b5-1 trading plan. This divestment follows a period of substantial stock …
Mattias Stetz, the Chief Operating Officer of Rush Street Interactive, Inc. (NASDAQ:RSI), has completed a sale of company stock totaling $561,878. The transaction involved 20,000 shares of Class A Common Stock and was carried out on May 1, 2026. This movement in equity comes at a time when RSI is experiencing significant momentum, with the stock tr…
Cole G. Carter, the Chief Administrative Officer at CoreCivic, Inc. (NASDAQ: CXW), has completed a sale of common stock totaling $258,000. The transaction occurred on May 1, 2026, involving the disposal of 12,500 shares at a price point of $20.64 per share. This move comes as CoreCivic manages a complex mix of strong financial performance and poten…
David E. Rainbolt, a director and ten percent owner of BancFirst Corp (NASDAQ: BANF), has completed a transaction involving the sale of common stock. The sale, which took place on April 29, 2026, involved a single share priced at $115.0 per share, totaling a transaction value of $115. This movement comes as BancFirst continues to navigate its finan…
James H. Dahl, a major stakeholder holding a 10% ownership interest in AMREP Corp. (NYSE:AXR), has increased his position in the company through two distinct series of transactions executed during late April and early May 2026. The total value of these recent acquisitions amounts to $222,256. These purchases took place while the stock was trading w…
Christine Ring, serving as the Chief Legal Officer for Nurix Therapeutics, Inc. (NASDAQ: NRIX), has completed a sale of company shares. The transaction, which took place on May 1, 2026, involved the disposal of 5,394 shares of common stock. This divestment was conducted in accordance with a Rule 10b5-1 trading plan that had been established by Ms. …
Beth Hecht, serving as the Chief Legal Officer and Corporate Secretary for Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), has completed a sale of company shares. The transaction, which took place on May 1, 2026, involved the disposal of 16,667 shares of common stock for a total value of $103,805. This move comes at a time when the company is naviga…
A group of major stakeholders in USCB Financial Holdings, Inc. (NASDAQ:USCB) has executed a series of stock sales totaling 50,000 shares of Class A Voting Common Stock. The selling group, which includes Patriot Financial Partners II, L.P., Patriot Financial Partners Parallel II, L.P., and various affiliated individuals and entities, realized approx…
Daniel S. Lorrain, the Chief Scientific Officer at Contineum Therapeutics, Inc. (NASDAQ: CTNM), has completed the sale of Class A Common Stock valued at approximately $54,694. The transactions, which took place on May 1, 2026, were executed through a pre-arranged 10b5-1 trading plan that was originally established on September 23, 2025. These sales…
Jim Wassil, the Chief Operating Officer of Vaxcyte, Inc. (NASDAQ: PCVX), has completed a sale of company common stock totaling $127,869. The transaction, which took place on May 1, 2026, involved the disposal of 2,250 shares. These shares were sold at prices ranging from $56.425 to $57.26 per share, representing a weighted average price of $56.831 …
Recent regulatory filings have disclosed stock transaction activity by D. Michael Kramer, a director at Covenant Logistics Group, Inc. (NASDAQ:CVLG). On April 29, 2026, Mr. Kramer executed two distinct transactions involving the company's Class A Common Stock, consisting of both a market sale and a charitable or gift-based disposition. These moves …
An SEC filing has revealed that Richard D. Gebert, a director at Independence Realty Trust, Inc. (NYSE:IRT), conducted a sale of company common stock on May 1, 2026. The transaction involved the disposal of 500 shares at a price point of $16.33 per share, resulting in total proceeds of $8,164. This specific divestment was carried out under a pre-es…
An SEC filing has revealed that Elizabeth Claire Ahmed, the Executive Vice President of People & Communications at Unum Group (NYSE: UNM), has executed a sale of company shares. The transaction took place on April 30, 2026, involving the disposal of 12,000 shares of common stock at a price point of $80.14 per share. This move resulted in total proc…
Shawn Soderberg, serving as the Chief Legal Officer and Corporate Secretary for Bloom Energy Corp (NASDAQ:BE), has completed a sale of Class A Common Stock totaling approximately $9,765,000. The transaction, which involved 35,000 shares, took place on April 29, 2026, at a price point of $279.00 per share. This divestment was executed via the Shawn …
Russell Skibsted, the Chief Financial Officer of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), has completed a direct purchase of company shares. The transaction occurred on April 30, 2026, representing an insider investment in the pharmaceutical firm at a time when the stock has faced considerable downward pressure in both the short and long term.…
James Edgemond, the Chief Financial Officer and Treasurer of United Therapeutics Corp (NASDAQ:UTHR), has completed a series of stock transactions totaling several million dollars. These moves, which included both the sale of common stock and the exercise of stock options, were conducted under a Rule 10b5-1 trading plan that was originally establish…
Martine A. Rothblatt, the Chairperson and CEO of United Therapeutics Corp (NASDAQ: UTHR), completed a series of transactions on April 30, 2026, involving the sale of common stock totaling approximately $5.44 million. The transaction was executed alongside an option exercise under a Rule 10b5-1 trading plan established in late 2025. This movement oc…
In a recent filing with the Securities and Exchange Commission, it was disclosed that Susan D. Lynch, a member of the board of directors at Crane Co. (NYSE: CR), has increased her stake in the company through a direct purchase of common stock. The transaction took place on April 30, 2026, involving the acquisition of 150 shares at a price point of …
